Stifel Nicolaus Trims Celsius (NASDAQ:CELH) Target Price to $51.00

Celsius (NASDAQ:CELH) had its price target cut by Stifel Nicolaus from $61.00 to $51.00 in a research note released on Thursday, Benzinga reports. They currently have a buy rating on the stock.

CELH has been the subject of a number of other reports. TD Cowen decreased their price target on shares of Celsius from $68.00 to $50.00 and set a buy rating for the company in a research note on Wednesday, August 7th. Piper Sandler decreased their target price on Celsius from $90.00 to $65.00 and set an overweight rating for the company in a research report on Wednesday, August 7th. Truist Financial dropped their price target on Celsius from $60.00 to $45.00 and set a hold rating on the stock in a research report on Friday, August 9th. Roth Mkm reduced their price target on Celsius from $75.00 to $65.00 and set a buy rating on the stock in a research note on Wednesday, August 7th. Finally, Maxim Group lowered their price objective on Celsius from $90.00 to $65.00 and set a buy rating for the company in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of Moderate Buy and an average price target of $57.64.

Celsius Stock Performance

Shares of CELH stock opened at $31.96 on Thursday. The firm has a market cap of $7.45 billion, a P/E ratio of 35.12, a P/E/G ratio of 1.57 and a beta of 1.90. The business’s 50 day moving average price is $45.15 and its 200-day moving average price is $66.48. Celsius has a fifty-two week low of $31.55 and a fifty-two week high of $99.62.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The business had revenue of $402.00 million for the quarter, compared to the consensus estimate of $391.07 million. During the same period in the previous year, the firm earned $0.17 EPS. The company’s quarterly revenue was up 23.4% compared to the same quarter last year. As a group, equities analysts predict that Celsius will post 1 EPS for the current year.

Institutional Trading of Celsius

Institutional investors and hedge funds have recently bought and sold shares of the company. Sanctuary Advisors LLC purchased a new stake in Celsius during the 2nd quarter valued at $2,827,000. Clearbridge Investments LLC bought a new position in shares of Celsius during the second quarter valued at $591,000. Cetera Investment Advisers boosted its position in shares of Celsius by 189.3% during the second quarter. Cetera Investment Advisers now owns 186,476 shares of the company’s stock valued at $10,646,000 after buying an additional 122,011 shares during the last quarter. B. Riley Wealth Advisors Inc. increased its holdings in Celsius by 269.6% in the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 9,917 shares of the company’s stock worth $566,000 after buying an additional 7,234 shares in the last quarter. Finally, Sunbelt Securities Inc. raised its position in Celsius by 41.4% in the 2nd quarter. Sunbelt Securities Inc. now owns 3,357 shares of the company’s stock worth $192,000 after buying an additional 983 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.